Altered status of glutathione and its metabolites in cystinotic cells
- PMID: 15956064
- DOI: 10.1093/ndt/gfh932
Altered status of glutathione and its metabolites in cystinotic cells
Abstract
Background: Cystinosis is an autosomal recessive disorder, caused by mutations of the lysosomal cystine carrier cystinosin, encoded by the CTNS gene (17p13). The concomitant intralysosomal cystine accumulation leads to multi-organ damage, with kidneys being the first affected. Altered mitochondrial oxidative phosphorylation has been demonstrated in animal proximal tubules loaded with cystine dimethyl ester, mimicking cystine accumulation in cystinosis, but has not been confirmed in cells of patients with cystinosis. Furthermore, the link between cystine accumulation and mitochondrial damage is also missing. We hypothesized that cytosolic cysteine deficiency resulting in intracellular glutathione (GSH) shortage might be involved in cellular dysfunction in cystinosis.
Methods: Components of the gamma-glutamyl cycle were measured in cultured skin fibroblasts (n = 9) and polymorphonuclear (PMN) leukocytes (n = 15) derived from patients with cystinosis and compared with the values in cultured fibroblasts (n = 9) and PMN cells (n = 18) of healthy controls.
Results: Cystine content in cystinotic fibroblasts and PMN cells was significantly elevated compared with the controls, consistent with the lysosomal cystine accumulation in these cells. Although no reduction of total intracellular GSH content was found in cystinotic cells, it inversely correlated with cystine levels. Furthermore, GSH disulfide (GSSG) was elevated in cystinotic cells, resulting in an increased GSSG/total GSH (%) ratio. No relationship between intracellular cystine and GSH was found in control fibroblasts and PMN cells.
Conclusion: An elevated GSSG/total GSH (%) ratio might indicate increased oxidative stress present in cystinotic cells. Inverse correlation between cystine accumulation and intracellular GSH content indicates that under stress conditions such as intensive energy demand or increased oxidative insult, cystinotic cells may be more prone to GSH depletion.
Similar articles
-
Elevated oxidized glutathione in cystinotic proximal tubular epithelial cells.Biochem Biophys Res Commun. 2005 Nov 18;337(2):610-4. doi: 10.1016/j.bbrc.2005.09.094. Epub 2005 Sep 23. Biochem Biophys Res Commun. 2005. PMID: 16202976
-
Glutathione precursors replenish decreased glutathione pool in cystinotic cell lines.Biochem Biophys Res Commun. 2004 Nov 5;324(1):231-5. doi: 10.1016/j.bbrc.2004.09.033. Biochem Biophys Res Commun. 2004. PMID: 15465007
-
Pantethine and cystamine deplete cystine from cystinotic fibroblasts via efflux of cysteamine-cysteine mixed disulfide.J Clin Invest. 1984 Aug;74(2):411-6. doi: 10.1172/JCI111436. J Clin Invest. 1984. PMID: 6746900 Free PMC article.
-
[From gene to disease: cystinosis].Ned Tijdschr Geneeskd. 2004 Mar 6;148(10):476-8. Ned Tijdschr Geneeskd. 2004. PMID: 15042893 Review. Dutch.
-
The pathogenesis of cystinosis: mechanisms beyond cystine accumulation.Am J Physiol Renal Physiol. 2010 Nov;299(5):F905-16. doi: 10.1152/ajprenal.00318.2010. Epub 2010 Sep 8. Am J Physiol Renal Physiol. 2010. PMID: 20826575 Review.
Cited by
-
Improvement in the renal prognosis in nephropathic cystinosis.Clin J Am Soc Nephrol. 2011 Oct;6(10):2485-91. doi: 10.2215/CJN.02000311. Epub 2011 Aug 25. Clin J Am Soc Nephrol. 2011. PMID: 21868618 Free PMC article.
-
N-acetyl-cysteine is associated to renal function improvement in patients with nephropathic cystinosis.Pediatr Nephrol. 2014 Jun;29(6):1097-102. doi: 10.1007/s00467-013-2705-3. Epub 2013 Dec 11. Pediatr Nephrol. 2014. PMID: 24326786 Clinical Trial.
-
Urine-Derived Kidney Progenitor Cells in Cystinosis.Cells. 2022 Apr 6;11(7):1245. doi: 10.3390/cells11071245. Cells. 2022. PMID: 35406807 Free PMC article.
-
Identification of oxygen-sensitive transcriptional programs in human embryonic stem cells.Stem Cells Dev. 2008 Oct;17(5):869-81. doi: 10.1089/scd.2007.0240. Stem Cells Dev. 2008. PMID: 18811242 Free PMC article.
-
Use of Human Induced Pluripotent Stem Cells and Kidney Organoids To Develop a Cysteamine/mTOR Inhibition Combination Therapy for Cystinosis.J Am Soc Nephrol. 2020 May;31(5):962-982. doi: 10.1681/ASN.2019070712. Epub 2020 Mar 20. J Am Soc Nephrol. 2020. PMID: 32198276 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases